PANC
PANACOS PHARMS INC by Panacos Pharmaceuticals, Inc. (PANC)
$00
About PANACOS PHARMS INC by Panacos Pharmaceuticals, Inc. (PANC)
Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
PANACOS PHARMS INC by Panacos Pharmaceuticals, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--